Abstract
Postsurgical hypoparathyroidism is a disorder characterized by hypocalcemia and low or absent parathyroid hormone (PTH). It is mainly caused by parathyroid devascularization, stunning, or incidental removal of the parathyroid gland(s) during thyroidectomy. The prevalence of postsurgical hypoparathyroidism in the Western world is estimated to be around 22 per 100,000 population. Symptoms probably depend on the degree and rapidity of hypocalcemia onset and are uncommon unless serum calcium level is below 2.0 mmol/L (8.0 mg/dL). These symptoms range from mild paresthesias and tingling to more severe cramps, tetany, seizures, laryngospasm, congestive heart failure, and arrhythmias due to prolonged QT intervals. Fortunately, only a minority of patients with transient hypoparathyroidism proceed to a state of permanent hypoparathyroidism, because of the recovery of the parathyroid glands from the surgical insult. It is currently difficult to predict which patients will recover, and it is unclear as to whether any specific intervention will facilitate recovery. Preoperative serum vitamin D, postoperative serum PTH, and postoperative changes in serum calcium levels should be considered predictors. The aim of hypoparathyroidism treatment is to keep the level of albumin-adjusted serum calcium at the lower end of the normal range to avoid the risk of hypercalcemia and hypercalciuria, which have the potential for renal impairment. For severe transient hypocalcemia, treatment could start with intravenous calcium gluconate. However, for mild hypocalcemia, oral calcium and calcitriol are usually used. Lack of response to oral therapy in the treatment of hypoparathyroidism following thyroidectomy has rarely been reported, and thus it is mandatory to exclude other potential causes of the hypocalcemia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359:391–403.
Edafe O, Antakia R, Laskar N, Uttley L, Balasubramanian SP. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg. 2014;101:307–20.
Khan MI, Waguespack SG, Hu MI. Medical management of postsurgical hypoparathyroidism. Endocr Pract. 2011;17:18–25.
Chadwick D, Kinsman R, Walton P, Systems DC. The British Association of Endocrine and Thyroid Surgeon fourth national audit. Henley-on-Thames: Dendrite Clinical Systems Ltd; 2012.
Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3660 patients. Langenbecks Arch Surg. 2008;393:667–73.
Terris DJ, Snyder S, Carneiro-Pla D, Inabnet 3rd WB, Kandil E, Orloff L, American Thyroid Association Surgical Affairs Committee Writing Task Force, et al. American Thyroid Association statement on outpatient thyroidectomy. Thyroid. 2013;23:1193–202.
Loyo M, Tufano RP, Gourin CG. National trends in thyroid surgery and the effect of volume on short-term outcomes. Laryngoscope. 2013;123(8):2056–63.
Hermann M, Ott J, Promberger R, Kober F, Karik M, Freissmuth M. Kinetics of serum parathyroid hormone during and after thyroid surgery. Br J Surg. 2008;95:1480–7.
RohJL PCI. Routine oral calcium and vitamin D supplements for prevention of hypocalcemia after total thyroidectomy. Am J Surg. 2006;192:675–8.
Sabour S, Manders E, Steward DL. The role of rapid PACU parathyroid hormone in reducing post thyroidectomy hypocalcemia. Otolaryngology. 2009;141:727–9.
Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg. 2004;28:271–6.
Mehanna HM, Jain A, Randeva H, Watkinson J, Shaha A. Postoperative hypocalcemia-the difference a definition makes. Head Neck. 2010;32:279–83.
Pradeep PV, Ramalingam K, Jayashree B. Post total thyroidectomy hypocalcemia: a novel multi-factorial scoring system to enable its prediction to facilitate an early discharge. J Postgrad Med. 2013;59:4–8.
Pradeep PV, Ramalingam K. Postoperative PTH measurement is not a reliable predictor for hypocalcemia after total thyroidectomy in vitamin D deficiency: prospective study of 203 cases. World J Surg. 2014;38:564–7.
Lang BH, Yih PC, Ng KK. A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy. World J Surg. 2012;36:1300–6.
Lo CY. Parathyroid autotransplantation during thyroidectomy. ANZ J Surg. 2002;72:902–7.
Asari R, Passler C, Kaczirek K, Scheuba C, Niederle B. Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg. 2008;143:132–7.
El-Sharaky MI, Kahalil MR, Sharaky O, Sakr MF, Fadaly GA, El-Hammadi HA, et al. Assessment of parathyroid autotransplantation for preservation of parathyroid function after total thyroidectomy. Head Neck. 2003;25:799–807.
Erbil Y, Bozbora A, Ozbey N, Issever H, Aral F, Ozarmagan S, et al. Predictive value of age and serum parathormone and vitamin D3 levels for postoperative hypocalcemia after total thyroidectomy for nontoxic multinodular goiter. Arch Surg. 2007;142:1182–7.
Erbil Y, Barbaros U, Temel B, Turkoglu U, Issever H, Bozbora A, et al. The impact of age, vitamin D level, and incidental parathyroidectomy on postoperative hypocalcemia after total or near total thyroidectomy. Am J Surg. 2009;197:439–46.
Erbil Y, Ozbey NC, Sari S, Unalp HR, Agcaoglu O, Ersoz F, et al. Determinants of postoperative hypocalcemia in vitamin D-deficient Graves’ patients after total thyroidectomy. Am J Surg. 2011;201:685–91.
Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S. Vitamin d and its relationship with obesity and muscle. Int J Endocrinol. 2014;2014:841248.
Al-Dhahri SF, Mubasher M, Al-Muhawas F, Alessa M, Terkawi RS, Terkawi AS. Early prediction of oral calcium and vitamin D requirements in post-thyroidectomy hypocalcaemia. Otolaryngol Head Neck Surg. 2014;151:407–14.
Promberger R, Ott J, Bures C, Kober F, Freissmuth M, Seemann R, Hermann M. Can a surgeon predict the risk of postoperative hypoparathyroidism during thyroid surgery? A prospective study on self-assessment by experts. Am J Surg. 2014;208:13–20.
Hoorn EJ, Zietse R. Disorders of calcium and magnesium balance: a physiology-based approach. Pediatr Nephrol. 2013;28:1195–206.
Vetter T, Lohse MJ. Magnesium and the parathyroid. Curr Opin Nephrol Hypertens. 2002;11:403–10.
Hammerstad SS, Norheim I, Paulsen T, Amlie LM, Eriksen EF. Excessive decrease in serum magnesium after total thyroidectomy for Graves’ disease is related to development of permanent hypocalcemia. World J Surg. 2013;37:369–75.
Bilezikian J, Khan A, Potts Jr J, Brandi M, Clarke B, Shoback D, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26:2317–37.
Alhefdhi A, Mazeh H, Chen H. Role of postoperative vitamin D and/or calcium routine supplementation in preventing hypocalcemia after thyroidectomy: a systematic review and meta-analysis. Oncologist. 2013;18:533–42.
Romagnoli E, Pepe J, Piemonte S, Cipriani C, Minisola S. Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol. 2013;169:R59–69.
Sitges-Serra A, Ruiz S, Girvent M, Manjon H, Duenas JP, Sancho JJ. Outcome of protracted hypoparathyroidism after total thyroidectomy. Br J Surg. 2010;97:1687–95.
Antakia R, Edafe O, Uttley L, Balasubramanian S. Effectiveness of preventative and other surgical measures on hypocalcaemia following bilateral thyroid surgery: a systematic review and meta-analysis. Thyroid. 2015;25:95–106.
Rejnmark L, Underbjerg L, Sikjaer T. Therapy of hypoparathyroidism by replacement with parathyroid hormone. Scientifica (Cairo). 2014;2014:765629.
Piemonte S, Romagnoli E, Bratengeier C, Woloszczuk W, Tancredi A, Pepe J, et al. Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone. J Endocrinol Invest. 2012;35:866–8.
Rubin MR, Dempster DW, Sliney Jr J, Zhou H, Nickolas TL, Stein EM, et al. PTH (1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res. 2011;26:2727–36.
Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, et al. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res. 2012;27:1811–20.
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42 Suppl 3:S1–201.
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Post-surgical hypoparathyroidism – risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res. 2014;29:2504–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pepe, J., Minisola, S. (2016). A Case with Postsurgical Hypoparathyroidism. In: Cooper, D., Durante, C. (eds) Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-22401-5_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-22401-5_20
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22400-8
Online ISBN: 978-3-319-22401-5
eBook Packages: MedicineMedicine (R0)